Background A quadrivalent vaccine that prevents genital warts (GWs) has been
recommended by the Advisory Committee on Immunization Practices for women since 2007 …

Objectives To assess the effectiveness of the HPV vaccines in preventing genital warts (GW)
in women aged 14–23 years and to estimate the incidence of GW in the whole population …

Background Approximately 90% of genital warts are caused by human papillomavirus (HPV)
types 6 and 11. In the United States, HPV vaccination has been recommended for girls and …

Background. Diagnoses of genital warts (GW) in genitourinary medicine (GUM) clinics have
been increasing in England for many years. In 2008, an HPV immunization program began …

Background The placebo arm of human papillomavirus (HPV) vaccine trials helps define the
natural history of genital warts (GW) Methods Women enrolled in the placebo arm (n= 8800) …

Background Information on genital wart incidence in adolescents and young adults before
human papillomavirus (HPV) vaccination is important for understanding the impact of the …

Background. Data on the natural history of human papillomavirus (HPV)–related genital
warts (GWs) in men are sparse. We described the distribution of HPV types in incident GWs …

Genital warts (GW) are mucosal or skin lesions caused by sexual transmission of human
papillomavirus (HPV). This study estimates the frequency of GW cases in physicians' clinics …

Human papillomavirus (HPV) is the most common sexually transmitted infection among US
military members. The most frequent clinical manifestation of HPV is genital warts (GW). This …

Background The impact of fewer than 3 doses of human papillomavirus (HPV) vaccine on
genital warts is uncertain. Methods Using the Truven Health Analytics Marketscan …